Condition
Experimental Pain
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 1 (1)
Trial Status
Completed2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT05763758UnknownPrimary
Spatiotemporal Thalamocortical Alterations Underlie Experimental and Chronic Pain
NCT02596360Phase 1CompletedPrimary
Dextromethorphan Effect on Central Sensitization to Pain in Healthy Volunteers
NCT00314392Not ApplicableCompletedPrimary
Gender, Pain, and Placebo Analgesia
Showing all 3 trials